NXP Semiconductors
Table 3: Condensed consolidated statement of cash flows (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| September 29, 2024 | June 30, 2024 | October 1, 2023 | |||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ | 729 | $ | 664 | $ | 792 | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | |||||||||||
| Depreciation and amortization | 218 | 213 | 273 | ||||||||
| Share-based compensation | 115 | 114 | 103 | ||||||||
| Amortization of discount (premium) on debt, net | — | 1 | 1 | ||||||||
| Amortization of debt issuance costs | 2 | 1 | 2 | ||||||||
| Results relating to equity-accounted investees | 6 | 3 | 2 | ||||||||
| (Gain) loss on equity securities, net | 7 | 3 | 4 | ||||||||
| Deferred tax expense (benefit) | (40 | ) | (23 | ) | (33 | ) | |||||
| Changes in operating assets and liabilities: | |||||||||||
| (Increase) decrease in receivables and other current assets | (167 | ) | 10 | 40 | |||||||
| (Increase) decrease in inventories | (86 | ) | (46 | ) | (34 | ) | |||||
| Increase (decrease) in accounts payable and other liabilities | 118 | (220 | ) | (128 | ) | ||||||
| (Increase) decrease in other non-current assets | (134 | ) | 40 | (49 | ) | ||||||
| Exchange differences | 7 | 5 | 5 | ||||||||
| Other items | 4 | (4 | ) | 10 | |||||||
| Net cash provided by (used for) operating activities | 779 | 761 | 988 | ||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of identified intangible assets | (26 | ) | (55 | ) | (42 | ) | |||||
| Capital expenditures on property, plant and equipment | (186 | ) | (185 | ) | (200 | ) | |||||
| Proceeds from the disposals of property, plant and equipment | — | 1 | — | ||||||||
| Purchase of investments | (159 | ) | — | (31 | ) | ||||||
| Net cash provided by (used for) investing activities | (371 | ) | (239 | ) | (273 | ) | |||||
| Cash flows from financing activities: | |||||||||||
| Dividends paid to common stockholders | (259 | ) | (260 | ) | (262 | ) | |||||
| Proceeds from issuance of common stock through stock plans | 39 | 3 | 36 | ||||||||
| Purchase of treasury shares and restricted stock unit
withholdings | (305 | ) | (310 | ) | (306 | ) | |||||
| Other, net | (1 | ) | — | (1 | ) | ||||||
| Net cash provided by (used for) financing activities | (526 | ) | (567 | ) | (533 | ) | |||||
| Effect of changes in exchange rates on cash positions | 7 | (4 | ) | (3 | ) | ||||||
| Increase (decrease) in cash and cash equivalents | (111 | ) | (49 | ) | 179 | ||||||
| Cash and cash equivalents at beginning of period | 2,859 | 2,908 | 3,863 | ||||||||
| Cash and cash equivalents at end of period | 2,748 | 2,859 | 4,042 | ||||||||
| Net cash paid during the period for: | |||||||||||
| Interest | 27 | 86 | 38 | ||||||||
| Income taxes, net of refunds | 196 | 193 | 165 | ||||||||
| Net gain (loss) on sale of assets: | |||||||||||
| Cash proceeds from the sale of assets | — | 1 | — | ||||||||
| Book value of these assets | — | (1 | ) | — | |||||||
| Non-cash investing activities: | |||||||||||
| Non-cash capital expenditures | 125 | 166 | 167 | ||||||||
